Augmenix, Inc.

Get Full Access

Description

  • Augmenix, Inc. is a privately held medical device company focused on the development and commercialization of radiation oncology and urology products using its proprietary hydrogel technology. The company is using this technology to develop products that decrease unintended radiation damage to normal organs during cancer radiation therapy and to mark soft tissue. The SpaceOAR System (OAR stands for organ at risk) is an absorbable hydrogel that temporarily moves the rectum away from the prostate and the high intensity radiation zone, protecting the rectum in men undergoing radiation therapy for prostate cancer. Clinically proven, the created space reduces rectal radiation injury and the resulting long term complications. It is the first and only prostate cancer spacing device to receive Food and Drug Administration (FDA) clearance.Additionally, Augmenix has developed an absorbable tissue marker that marks soft tissue for a surgical procedure or future surgical procedures. TraceIT Tissue Marker is visible on multi-modality imaging allowing for improved tissue marking.This technology, licensed from Incept, LLC, comes from a line of products that have made a meaningful impact in the areas of neurosurgery and interventional cardiology. Augmenix is bringing this technology to the field of radiation oncology through high quality investors and an experienced management team.Augmenix, SpaceOAR, and SpaceOAR logo are registered trademarks of Augmenix, Inc.
  • location

    Headquarters:204 Second Avenue , Waltham, Massachusetts, United States

    More
  • Augmenix, Inc. phone

    Phone Number: +1 781-932-0222

  • Augmenix, Inc. website

    Website: https://www.augmenix.com

  • Augmenix, Inc. employees

    Employees:81

  • Augmenix, Inc. revenue

    Revenue:$10 - 50M

  • Augmenix, Inc. legal name

    Legal Name:Augmenix, Inc.

  • Augmenix, Inc.'s Social Media

    Augmenix, Inc. linkedin Augmenix, Inc. facebook Augmenix, Inc. twitter
  • done Is this data correct?
  • |  NAICS Code: 332994  |

    Show More
Person level website identification

CEO for Augmenix, Inc.

Amar Sawhney

President And Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Robert Ascoli

Vice President Of Sales And Marketing

Carey Manning

Assoc Director Of Sales And Marketing Analytics

Eileen Gardner

Director Of Marketing

Stephanie Bye

Sales Manager, Nw Region

Sameera Dasari

Clinical Project Manager

Frequently Asked Questions regarding Augmenix, Inc.

  • Where are Augmenix, Inc.'s Headquarters?

    Augmenix, Inc.'s Headquarters are in 204 Second Avenue ,Waltham,Massachusetts,United States

  • What is Augmenix, Inc.'s phone number?

    Augmenix, Inc.'s phone number is +1 781-932-0222

  • What is Augmenix, Inc.'s official website?

    Augmenix, Inc.'s official website is https://www.augmenix.com

  • What is Augmenix, Inc.'s Revenue?

    Augmenix, Inc.'s revenue is $10 - 50M

  • What is Augmenix, Inc.'s NAICS code?

    Augmenix, Inc.'s NAICS code is 332994

  • How many employees are working in Augmenix, Inc.

    Augmenix, Inc. has 81 employees

  • What is Augmenix, Inc.'s Industry?

    Augmenix, Inc. is in the industry of Medical Devices

  • Who is Augmenix, Inc.'s CEO?

    Augmenix, Inc.'s CEO is Amar Sawhney

Company Directory